CLBT Stock: Price, Forecast, Financials & AI Analysis

Loading chart...

High

13.740

Open

13.670

VWAP

13.55

Vol

1.62M

Mkt Cap

3.40B

Low

13.290

Amount

21.91M

EV/EBITDA(TTM)

35.78

Total Shares

249.44M

2.96B

EV/OCF(TTM)

17.06

P/S(TTM)

7.15

Cellebrite DI Ltd is an Israel-based company engaged primarily in the software sector. The Company is committed to providing a Digital Intelligence (DI) platform for managing DI in legally sanctioned investigations. The Company provides solutions for the public and private sectors, enabling organizations in mastering the complexities of legally sanctioned digital investigations by streamlining intelligence processes. The Company's platform and solutions transform how customers collect, review, analyze and manage data in legally sanctioned investigations. The Company aims to enable its customers to protect and save lives, accelerate justice, and preserve privacy in communities around the world.

Events Timeline

(ET)

2026-05-06

08:50:00

Cellebrite Government Cloud Achieves FedRAMP High Authorization

2026-03-16 (ET)

2026-03-16

08:50:00

Cellebrite Launches Revolutionary AI Product Genesis

2026-02-11 (ET)

2026-02-11

07:11:00

Cellebrite Q4 Revenue $128.8M Beats Expectations

2026-02-11

07:10:00

Sees Q1 Adjusted EBITDA of $26M-$28M

News

9.5

12:07 PMFool

Alphabet's Stock Surge Raises Bubble Concerns

1.0

05-08PRnewswire

Cellebrite to Participate in Multiple Investor Conferences

1.0

05-08PRnewswire

Cellebrite to Participate in Multiple Investor Conferences

1.0

05-08PRnewswire

Cellebrite to Participate in Multiple Investor Conferences

1.0

05-08PRnewswire

Cellebrite to Participate in Multiple Investor Conferences

8.5

05-06PRnewswire

Cellebrite Secures FedRAMP High Authorization for Government Cloud

7 Analyst Rating

Wall Street analysts forecast CLBT stock price to rise

7 Buy

0 Hold

0 Sell

Strong Buy

Current: 0.000

Low

23.00

Averages

24.83

High

28.00

Current: 0.000

Low

23.00

Averages

24.83

High

28.00

Needham

Buy

downgrade

$24 -> $18

AI Analysis

2026-02-12

Reason

Needham

Price Target

$24 -> $18

AI Analysis

2026-02-12

downgrade

Buy

Reason

Needham lowered the firm's price target on Cellebrite to $18 from $24 but keeps a Buy rating on the shares. The company outperformed guidance and expectations, with total ARR growing 21% y/y, while the management's 2026 outlook lived up to commentary on the prior earnings call for conviction in an ARR re-acceleration, the analyst tells investors in a research note.

TD Cowen

Buy

downgrade

$25 -> $23

2026-02-12

Reason

TD Cowen

Price Target

$25 -> $23

2026-02-12

downgrade

Buy

Reason

TD Cowen lowered the firm's price target on Cellebrite to $23 from $25 and keeps a Buy rating on the shares. The firm said based on market contraction, they are lowering their target following solid 4Q25 results headlined by 21% ARR growth, 21% subscription revenue growth, and solid 2026 guidance.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for CLBT

Unlock Now

Valuation Metrics

The current forward P/E ratio for Cellebrite DI Ltd (CLBT.O) is 35.71, compared to its 5-year average forward P/E of 46.22. For a more detailed relative valuation and DCF analysis to assess Cellebrite DI Ltd's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

5Y Average PE

46.22

Current PE

35.71

Overvalued PE

69.46

Undervalued PE

22.98

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

5Y Average EV/EBITDA

28.12

Current EV/EBITDA

28.07

Overvalued EV/EBITDA

39.85

Undervalued EV/EBITDA

16.40

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

5Y Average PS

5.60

Current PS

5.19

Overvalued PS

7.96

Undervalued PS

3.23

Financials

AI Analysis

Annual

Quarterly

Related Community Screener

best swing trades $10-$20

Intellectia · 209 candidates

Price: $10.00 - $20.00Rsi Category: moderateMoving Average Relationship: PriceAboveMA20Week Price Change Pct: $-5.00 - $15.00Macd: bullish

Ticker

Name

Market Cap$

CLBT

Cellebrite DI Ltd

3.79B

AEVA

Aeva Technologies Inc

901.80M

SPMC

Sound Point Meridian Capital Inc

217.22M

NAVN

Navan Inc

2.58B

GPRE

Green Plains Inc

1.06B

UMAC

Unusual Machines Inc

559.45M

let me seethedaytrading stocks

Intellectia · 41 candidates

Price: $5.00 - $50.00Relative Vol: >= 2Beta: HighRiskWeekly Average Turnover: >= 2,000,000

Ticker

Name

Market Cap$

NEOV

NeoVolta Inc

191.06M

CNTA

Centessa Pharmaceuticals PLC

3.39B

ZURA

Zura Bio Ltd

410.95M

IPI

Intrepid Potash Inc

456.52M

DCOM

Dime Community Bancshares Inc

1.44B

CLBT

Cellebrite DI Ltd

3.85B

find stock with increasing volume

Intellectia · 114 candidates

Market Cap: 500.00M - 5.00BRelative Vol: >= 2

Ticker

Name

Market Cap$

PLXS

Plexus Corp

4.86B

MIRM

Mirum Pharmaceuticals Inc

4.82B

IEP

Icahn Enterprises LP

4.81B

SFBS

ServisFirst Bancshares Inc

4.78B

RUSHB

Rush Enterprises Inc

4.68B

TCBI

Texas Capital Bancshares Inc

4.67B

what stock is bearish today

Intellectia · 65 candidates

Relative Vol: >= 2Moving Average Relationship: PriceBelowMA20Candlestick Pattern: BlackCandlestickWeek Price Change Pct: <= $-3.00Support Resistance Relationship: PriceFallBelowSupport

Ticker

Name

Market Cap$

ABT

Abbott Laboratories

209.93B

SHOP

Shopify Inc

180.36B

NET

Cloudflare Inc

59.54B

SRE

Sempra

56.12B

Broadridge Financial Solutions Inc

24.15B

EQH

Equitable Holdings Inc

13.11B

Whales Holding CLBT

More Investment House Ltd.

Clal Financial Management Ltd

Meitav Investment House Ltd

Portolan Capital Management, LLC

Migdal Mutual Funds Ltd.

Phoenix Investments & Finances Ltd

Trading Trends

People Also Watch

Frequently Asked Questions

What is Cellebrite DI Ltd (CLBT) stock price today?

The current price of CLBT is 13.62 USD — it has decreased -1.38

What is Cellebrite DI Ltd (CLBT)'s business?

What is the price predicton of CLBT Stock?

Wall Street analysts forecast CLBT stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CLBT is24.83 USD with a low forecast of 23.00 USD and a high forecast of 28.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Cellebrite DI Ltd (CLBT)'s revenue for the last quarter?

Cellebrite DI Ltd revenue for the last quarter amounts to 128.82M USD, increased 18.13

What is Cellebrite DI Ltd (CLBT)'s earnings per share (EPS) for the last quarter?

Cellebrite DI Ltd. EPS for the last quarter amounts to 0.08 USD, decreased 0.00

How many employees does Cellebrite DI Ltd (CLBT). have?

Cellebrite DI Ltd (CLBT) has 1285 emplpoyees as of May 11 2026.

What is Cellebrite DI Ltd (CLBT) market cap?

Today CLBT has the market capitalization of 3.40B USD.

CLBT Overview

CLBT Overview

Events Timeline

News

Valuation Metrics

Forward PE

Forward EV/EBITDA

Forward PS

Financials

Related Community Screener

Whales Holding CLBT

Trading Trends

People Also Watch

Frequently Asked Questions

What is Cellebrite DI Ltd (CLBT) stock price today?

What is Cellebrite DI Ltd (CLBT)'s business?

What is the price predicton of CLBT Stock?

What is Cellebrite DI Ltd (CLBT)'s revenue for the last quarter?

What is Cellebrite DI Ltd (CLBT)'s earnings per share (EPS) for the last quarter?

How many employees does Cellebrite DI Ltd (CLBT). have?

What is Cellebrite DI Ltd (CLBT) market cap?